Search Count: 5
 |
O-Glcnacase (Oga) Inhibitor Complex For The Treatment Of Alzheimer'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.54 Å Release Date: 2025-01-15 Classification: HYDROLASE Ligands: A1AKM |
 |
O-Glcnacase (Oga) Inhibitor Complex For The Treatment Of Alzheimer'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2025-01-15 Classification: HYDROLASE Ligands: A1AKL |
 |
Mark2 Complex With 7-[(1S)-1-(4-Fluorophenyl)Ethyl]-5,5-Dimethyl-2-(3-Pyridylamino)Pyrrolo[2,3-D]Pyrimidin-6-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.20 Å Release Date: 2017-05-31 Classification: Transferase/Transferase Inhibitor Ligands: 6Z2 |
 |
Mark2 Complex With 7-[(1S)-1-(4-Fluorophenyl)Ethyl]-5,5-Dimethyl-2-(3-Pyridylamino)Pyrrolo[2,3-D]Pyrimidin-6-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.21 Å Release Date: 2017-05-31 Classification: Transferase/Transferase Inhibitor Ligands: 6Z5 |
 |
Optimization Of Microtubule Affinity Regulating Kinase (Mark) Inhibitors With Improved Physical Properties
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2016-02-17 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 24R |